Manufacturer record
Glenmark Pharmaceuticals Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
12 batches manufactured by Glenmark Pharmaceuticals Ltd (Sikkim) were declared Not of Standard Quality between May 2021 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: GLB26001, Telmisartan And Metoprolol Succinate Extended Release Tablets (40 mg+50 mg) (exp Jan 2028). LUCKNOW, Uttar Pradesh (state lab) found it not of standard quality: The sample does not conform to declared formula, in respect of content of Telmisartan. Listed in the September 2026 alert.
Records by type
12 records linked to Glenmark Pharmaceuticals Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Telmisartan And Metoprolol Succinate Extended Release Tablets (40 mg+50 mg) | Batch GLB26001Mfg Feb 2026 · Exp Jan 2028 | The sample does not conform to declared formula, in respect of content of TelmisartanOther | LUCKNOW, Uttar PradeshState lab | Sep 2026 |
| Telmisartan 40 mg and Amlodipine 5 mg Tablets IP | Batch 18250527Mfg Oct 2025 · Exp Sep 2028 | The sample does not conform to IP in respect of Dissolution of TelmisartanDissolution | LUCKNOW, Uttar PradeshState lab | Sep 2026 |
| Telmisartan 40 mg and Amlodipine 5mg tablets IP | Batch 18240554Mfg Jul 2024 · Exp Jun 2027 | Test For Assay (Content) Of TelmisartanAssay | DTL, DelhiState lab | Aug 2026 |
| Clotrimazole and Selenium Sulfide Suspension, candid tv | Batch 46230305Mfg Dec 2023 · Exp Nov 2025 | Sample does not conform to label claim with respect to identification and the content of clotrimazole (Deemed to be spurious)Identification | DTL MaduraiState lab | Apr 2025 |
| Telma H (Telmisartan 40 mg and Hydrochlorot hiazide 12.5mg Tablets IP) | Batch 18230080Mfg Feb 2023 · Exp Jan 2026 | Dissolution & Assay of TelmisartanAssay | Not applicableCDSCO lab | Aug 2024 |
| CANDITRAL 100 (ITRACONAZOLE CAPSULE B.P. 100 MG) | Batch 5230123Mfg Jan 2023 · Exp Jun 2025 | THE SAMPLE DOES NOT COMPLY WITH B P REQUIREMENTS FOR DISSOLUTION TESTDissolution | State Lab MaharashtraState lab | Jun 2024 |
| Ziten Tablets (Teneligliptin Tablets IP 20 mg) | Batch 18220672Mfg Sep 2022 · Exp Aug 2024 | DissolutionDissolution | CDTL ChennaiCDSCO lab | Apr 2023 |
| Telmisartan 40 mg and Amlodipine 5 mg Tablets IP (Telma-AM Tablets) | Batch 18220076Mfg Jan 2022 · Exp Dec 2024 | Dissolution of TelmisartanDissolution | RDTL ChandigarhState lab | Mar 2023 |
| Telma 40 (Telmisartan Tablets I.P. 40 mg) | Batch 18220015Mfg Jan 2022 · Exp Dec 2024 | Identification & AssayAssay | CDL KolkataCDSCO lab | Feb 2023 |
| Hydroxyzine HCl IP /BP | Batch 225004009Mfg Aug 2022 · Exp Jul 2027 | Appearance of solutionOther | CDTL MumbaiCDSCO lab | Jan 2023 |
| Telmisartan 40 mg and Hydrochlorothiazide 12.5 mg Tablets IP (TELMA H TABLETS) | Batch 18200994Mfg Oct 2020 · Exp Sep 2023 | Assay of TelmisartanAssay | RDTL ChandigarhState lab | Feb 2022 |
| Telmisartan 40 mg and Amlodipine 5 mg Tablets IP (TELMA-AM TABLETS) | Batch 5201874Mfg Oct 2020 · Exp Sep 2023 | Dissolution of AmlodipineDissolution | RDTL ChandigarhState lab | May 2021 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.